In non-excitable cells, the predominant mechanism for regulated entry of Ca 2+ is capacitative calcium entry, whereby depletion of intracellular Ca 2+ stores signals the activation of plasma membrane calcium channels. A number of other regulated Ca 2+ entry pathways occur in specific cell types, however, and it is not know to what degree the different pathways interact when present in the same cell. In this study, we have examined the interaction between capacitative calcium entry and arachidonic acid-activated calcium entry which co-exist in HEK293 cells.
Introduction
In non-excitable cells, the major mechanism for receptor-regulated Ca 2+ signaling involves activation of polyphosphoinositide-specific phospholipase C, formation of inositol 1,4,5-trisphosphate (IP 3 ) and release of intracellular stored Ca 2+ by activation of IP 3 receptor/ion channels in the endoplasmic reticulum (1) . The decline in Ca 2+ content of the intracellular stores then secondarily signals the activation of plasma membrane calcium channels, a process known as capacitative calcium entry (2;3). Recent studies have indicated that the channels in the plasma membrane may be members of the TRP family of channel proteins (4-7). The mechanism of coupling intracellular stores to the plasma membrane channels may involve direct interactions between the channel molecules and underlying IP 3 receptors (8) (9) (10) (11) .
Although capacitative calcium entry appears to be present ubiquitously in receptorregulated non-excitable cells, other mechanisms for signaling entry have been found in specific cell types. Examples include receptor-gated channels (12) , and channels activated by second messengers such as cyclic nucleotides (13) , phosphatidylinositol 3,4,5-trisphosphate (14) and arachidonic acid (15;16) (for a review see (17;18)). In the HEK293 cell line, capacitative and non-capacitative pathways co-exist (19;20) . In these cells, muscarinic receptor activation can lead to baseline [Ca 2+ ] i spikes or [Ca 2+ ] i oscillations. However, despite the discharge of stored Ca 2+ during these spikes, the calcium entry necessary for maintaining continuous spiking appears to be non-capacitative (16). Also, in this cell line arachidonic acid induces a non-capacitative calcium entry; as to whether this response represents the non-capacitative mechanism seen with low concentrations of muscarinic agonists is controversial (21) . Nonetheless, when exogenous arachidonic acid is used to activate entry in HEK293 cells, significant discharge of stored calcium occurs, yet little if any capacitative entry is activated (see below). Collectively, these observations suggest some degree of interaction between the capacitative and non-capacitative arachidonic acid-mediated pathways. Thus, in the current study we have carried out experiments to examine the regulation of these two calcium entry mechanisms, and specifically to determine in what ways the signaling pathways interact. Our findings indicate that although both pathways involve the release of a common intracellular calcium pool, the entry components of the two pathways operate in a mutually exclusive manner. This implies that the underlying signaling mechanisms may be able to interact in a way that prevents the occurrence of supramaximal activation of calcium entry which could have potentially toxic effects on cell function.
Materials and Methods
Cell Culture: Human embryonic kidney 293 (HEK293) cells obtained from ATCC were grown at 37° C in Dulbecco's Eagle's medium (DMEM) supplemented with 10% heatinactivated fetal bovine serum and 2 mM glutamine in a humidified 95% air, 5% CO 2 incubator.
For Ca 2+ measurements, cells were cultured to about 70% confluence, passaged onto glass coverslips and used 24-48 h after plating.
Fluorescence measurements: Fluorescence measurements were made with Fura2-loaded Materials: Arachidonic acid was obtained from BioMol (PA, USA). Carbachol and thapsigargin were purchased from Calbiochem (CA, USA). 2-aminoethyoxydiphenyl borane (2-APB) was synthesized as previously described (23) .
Statistics: For some experiments, average peak responses (F340/F380) were calculated and expressed as mean ± S.E.M. for the indicated number (n) of experiments. Statistical significance was determined with the Student's t test (P <0.05).
Results and Discussion
Thapsigargin and arachidonic acid discharge the same intracellular Ca 2+ pool. Treatment of HEK293 cells with either 1 µM thapsigargin or 30 µM arachidonic acid causes a release of intracellular stored Ca 2+ as well as an increase in Ca 2+ entry across the plasma membrane ( Fig.   1 ). Yet, 1 µM Gd 3+ completely blocks the thapsigargin-induced entry with little effect on the entry due to arachidonic acid (Fig 1) . Thus, arachidonic acid appears to release Ca 2+ stores but, unlike thapsigargin, arachidonic acid does not activate significant capacitative calcium entry. We Mutual antagonism of the capacitative and arachidonic acid-activated calcium entry pathways. One possible explanation for the failure of arachidonic acid to activate capacitative calcium entry is that arachidonic acid may act as an inhibitor of these channels or of some other step in the influx mechanism. There is precedence for this idea, as unsaturated fatty acids (24) , and specifically arachidonic acid (25) have been shown to inhibit capacitative calcium entry in other systems. In the experiment shown in Fig. 3 , HEK293 cells were treated with thapsigargin in the absence of extracellular Ca 2+ , and then Ca 2+ was restored as indicated, revealing a robust 
Pre-activation of capacitative calcium entry inhibits arachidonic acid-induced Ca 2+
entry. To investigate the effects of activation of capacitative calcium entry on arachidonic acidmediated Ca 2+ entry, we carried out the experiment illustrated in Fig. 4 . The membrane permeant IP 3 receptor antagonist, 2-APB (23) has been shown to inhibit capacitative calcium entry, and there is evidence that it acts on the channels in a manner that interferes with the signaling mechanism (26). However, arachidonic acid-induced entry of Ca 2+ is not inhibited by this reagent (Ref. (21) , and see below). HEK293 cells, in the presence of extracellular Ca 2+ , were treated with 100 µM 2-APB as indicated in Fig. 4 , and subsequent addition of thapsigargin resulted in a transient response indicating inhibition of capacitative calcium entry. When arachidonic acid was Luo et al., Page 8 subsequently added, a robust [Ca 2+ ] i rise was observed; since intracellular stores were previously released by thapsigargin, this indicates that under this experimental condition, arachidonic acid is capable of activation of Ca 2+ entry.
In the experiment shown in Fig. 5 , we repeated this protocol utilizing another reagent that selectively blocks capacitative calcium entry, 1 µM Gd 3+ ((27) Fig. 1 ). However, while as for 2-APB Gd 3+ prevented Ca 2+ entry in response to thapsigargin, arachidonic acid now failed to activate a [Ca 2+ ] i signal.
This latter result indicates that depletion of Ca 2+ stores by thapsigargin in some manner inhibits the ability of arachidonic acid to activate the non-capacitative calcium entry pathway.
The difference in the mechanism of action of 2-APB and Gd 3+ is therefore critical to understanding the nature of this interaction. Although the action of 2-APB on capacitative calcium entry channels may not, as first proposed, result from inhibition of inositol trisphosphate receptors (28), there is nonetheless evidence that its mode of interaction may involve the interference with the coupling mechanism rather than by acting simply as a blocker of the channel pore (26) .
Gd 3+ , on the other hand, would be expected to block the channels directly. The known actions of thapsigargin are inhibition of SERCA pumps, depletion of Ca 2+ stores, and entry of Ca 2+ through activated capacitative calcium entry channels (29) . Neither inhibition of SERCA pumps nor depletion of Ca 2+ stores can be responsible because 2-APB blocks the interaction (Fig. 5) Luo et al., Page 9 without interfering with the ability of thapsigargin to deplete Ca 2+ stores. The entry of Ca 2+ cannot be important because this is blocked by Gd 3+ , yet this agent does not prevent the inhibition by thapsigargin of arachidonic acid-induced entry. We conclude that a 2-APB sensitive step in the signaling pathway for capacitative calcium entry acts to inhibit the activation of non-capacitative calcium entry channels by arachidonic acid. The nature of this step is unknown. Clearly, we must first achieve a better understanding of the steps involved in signaling capacitative calcium entry in order to determine how this pathway interacts with and regulates the arachidonic acid pathway or other calcium signaling pathways. Note that despite the findings indicating that 2-APB does not block capacitative calcium entry by virtue of its action on inositol trisphosphate receptors, an inescapable conclusion from the current findings is that this reagent must be doing something more than simply acting as a channel blocker.
Although unlikely, an alternative interpretation of the findings in Figures 4 and 5 is that somehow treatment with thapsigargin causes arachidonic-acid activated channels to become Gd 3+ -sensitive. To examine this possibility, we repeated the protocol of Figures 4 and 5 utilizing both Gd 3+ and 2-APB in combination. If thapsigargin causes arachidonic acid-regulated channels to become Gd 3+ -sensitive, the protocol should result in a block of the arachidonic acid-induced response. If 2-APB acts to prevent a store-depletion inhibitory effect on the channels, then arachidonic acid will give a normal response. The results of this experiment, shown in Figure 6 , show that the latter is indeed the case.
A somewhat similar mutual antagonism has been described recently for the interaction between nicotinic-and purinergic-regulated cation channels (30) . In this instance, the authors proposed close proximity between the interacting receptor/channel types. With respect to the current findings, there is evidence that arachidonic acid-regulated and capacitative calcium entry channels are located some undetermined distance apart in the plasma membrane (19) . Also, in the previous study on ligand-gated channels, the inhibitory interactions resulted in lack of additivity, but at least under the experimental conditions in our study, the degree of cross inhibition was even more striking (Figs. 3 and 5) .
What determines which of these pathways predominate when multiple upstream signals occur? The answer to this question may depend on a number of variables, such as stimulus strength of different initiating agonists. However, as shown in Fig. 1 , when arachidonic acid is applied, store depletion occurs, but clearly the arachidonic acid-activated entry predominates.
This would suggest that at least under this experimental protocol, the arachidonic acid pathway takes precedence.
In conclusion, the results of this study demonstrate for the first time a process of mutual antagonism between two distinct regulated Ca 2+ entry pathways. The function of this mutual antagonism cannot be known for certain, but it is reasonable to suggest that this represents a mechanism to protect cells from the toxic effects of excessive [Ca 2+ ] i loads. Thus, these two pathways exist as alternative pathways for Ca 2+ signaling, and the process of mutual antagonism Additional stores of Ca 2+ could be released by the Ca 2+ ionophore, ionomycin (second arrow).
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The experiment is representative of a total of 4 similar experiments. 
